Literature DB >> 23232509

Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells.

Elisa Cimetta1, Dario Sirabella, Keith Yeager, Kathryn Davidson, Joseph Simon, Randall T Moon, Gordana Vunjak-Novakovic.   

Abstract

During development and regeneration, tissues emerge from coordinated sequences of stem cell renewal, specialization and assembly that are orchestrated by cascades of regulatory signals. The complex and dynamic in vivo milieu cannot be replicated using standard in vitro techniques. Microscale technologies now offer potential for conducting highly controllable and sophisticated experiments at biologically relevant scales, with real-time insights into cellular responses. We developed a microbioreactor providing time sequences of space-resolved gradients of multiple molecular factors in three-dimensional (3D) cell culture settings, along with a versatile, high-throughput operation and imaging compatibility. A single microbioreactor yields up to 120 data points, corresponding to 15 replicates of a gradient with 8 concentration levels. Embryoid bodies (EBs) obtained from human embryonic and induced pluripotent stem cells (hESC, hiPSC) were exposed to concentration gradients of Wnt3a, Activin A, BMP4 and their inhibitors, to get new insights into the early-stage fate specification and mesodermal lineage commitment. We were able to evaluate the initiation of mesodermal induction by measuring and correlating the gene expression profiles to the concentration gradients of mesoderm-inducing morphogens. We propose that the microbioreactor systems combining spatial and temporal gradients of molecular and physical factors to hESC and hiPSC cultures can form a basis for predictable in vitro models of development and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23232509      PMCID: PMC3535552          DOI: 10.1039/c2lc40836h

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  37 in total

Review 1.  Out of Eden: stem cells and their niches.

Authors:  F M Watt; B L Hogan
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 2.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 3.  Personalized medicine: progress and promise.

Authors:  Isaac S Chan; Geoffrey S Ginsburg
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

4.  Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4.

Authors:  Kathryn C Davidson; Allison M Adams; Jamie M Goodson; Circe E McDonald; Jennifer C Potter; Jason D Berndt; Travis L Biechele; Russell J Taylor; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

Review 5.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

6.  A programmable microfluidic cell array for combinatorial drug screening.

Authors:  Jeongyun Kim; David Taylor; Nitin Agrawal; Han Wang; Hyunsoo Kim; Arum Han; Kaushal Rege; Arul Jayaraman
Journal:  Lab Chip       Date:  2012-03-28       Impact factor: 6.799

Review 7.  Induced pluripotent stem cells for modelling human diseases.

Authors:  Juli J Unternaehrer; George Q Daley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

8.  Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of β-catenin signaling.

Authors:  Elisa Cimetta; Christopher Cannizzaro; Richard James; Travis Biechele; Randall T Moon; Nicola Elvassore; Gordana Vunjak-Novakovic
Journal:  Lab Chip       Date:  2010-10-11       Impact factor: 6.799

9.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

10.  SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.

Authors:  Nicole C Dubois; April M Craft; Parveen Sharma; David A Elliott; Edouard G Stanley; Andrew G Elefanty; Anthony Gramolini; Gordon Keller
Journal:  Nat Biotechnol       Date:  2011-10-23       Impact factor: 54.908

View more
  25 in total

Review 1.  Advances in microfluidic platforms for analyzing and regulating human pluripotent stem cells.

Authors:  Tongcheng Qian; Eric V Shusta; Sean P Palecek
Journal:  Curr Opin Genet Dev       Date:  2015-08-24       Impact factor: 5.578

Review 2.  Concise review: microfluidic technology platforms: poised to accelerate development and translation of stem cell-derived therapies.

Authors:  Drew M Titmarsh; Huaying Chen; Nick R Glass; Justin J Cooper-White
Journal:  Stem Cells Transl Med       Date:  2013-12-05       Impact factor: 6.940

Review 3.  Engineering stem cell niches in bioreactors.

Authors:  Meimei Liu; Ning Liu; Ru Zang; Yan Li; Shang-Tian Yang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

4.  In Vitro Microscale Models for Embryogenesis.

Authors:  Jennifer Rico-Varela; Dominic Ho; Leo Q Wan
Journal:  Adv Biosyst       Date:  2018-05-07

Review 5.  Towards Three-Dimensional Dynamic Regulation and In Situ Characterization of Single Stem Cell Phenotype Using Microfluidics.

Authors:  Sébastien Sart; Spiros N Agathos
Journal:  Mol Biotechnol       Date:  2018-11       Impact factor: 2.695

Review 6.  "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells.

Authors:  Dario Sirabella; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-10

7.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

8.  Stem cell bioprocess engineering towards cGMP production and clinical applications.

Authors:  Sébastien Sart; Yves-Jacques Schneider; Yan Li; Spiros N Agathos
Journal:  Cytotechnology       Date:  2014-02-06       Impact factor: 2.058

Review 9.  Induced pluripotent stem cells for regenerative medicine.

Authors:  Karen K Hirschi; Song Li; Krishnendu Roy
Journal:  Annu Rev Biomed Eng       Date:  2014-05-29       Impact factor: 9.590

Review 10.  Bioreactor engineering of stem cell environments.

Authors:  Nina Tandon; Darja Marolt; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Biotechnol Adv       Date:  2013-03-24       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.